InvestorsHub Logo
Followers 126
Posts 5437
Boards Moderated 0
Alias Born 06/09/2020

Re: hyperopia post# 611960

Thursday, 07/20/2023 11:36:37 AM

Thursday, July 20, 2023 11:36:37 AM

Post# of 708785

And yes, it does sound to me as though the MHRA may create a new, accelerated pathway for cancer vaccines, perhaps from development through approval.



https://www.gov.uk/government/news/mhra-to-receive-10m-from-hm-treasury-to-fast-track-patient-access-to-cutting-edge-medical-products

MHRA to receive £10m from HM Treasury to fast-track patient access to cutting-edge medical products



The funding over the next two years will support development of a thorough but shortened process to speed up the approval process for cutting-edge treatments developed in the UK with the greatest opportunity to meet the UK’s healthcare priorities, such as cancer vaccines and AI-based therapeutics for mental ill-health.

HM Treasury has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.

Bullish
Bullish

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News